Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05014906 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Oral Minocycline (Solodyn) and Oral Minocycline (Solodyn) Plus Azelaic Acid (Finacea) for Acne Rosacea
A Phase 4 study of Rosacea, sponsored by Dermatology Specialists Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05014906: Completed Phase 4 study of Rosacea, sponsored by Dermatology Specialists Research.
NCT05014906 is a Phase 4 study of Rosacea that has completed, run by Dermatology Specialists Research. The registered enrollment target is 60 participants, below the 240-participant average among 23 other Rosacea trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05014906, a Phase 4 study of Rosacea, has completed, sponsored by Dermatology Specialists Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Rosacea is one of the most commonly occurring dermatoses treated by dermatologist today. Rosacea is an inflammatory condition of the skin presenting as flushing and or blushing along with redness, swelling, telangiectasia, and acne lesions. Minocycline has shown beneficial in the treatment of inflammatory acne lesions in patients with rosacea. This study is to evaluate the efficacy and tolerability of minocycline (Solodyn) alone versus minocycline (Solodyn) in combination with azelaic acid 15%(Finacea) in the treatment of rosacea.
Primary Outcome
The goal of analysis is to assess evidence of overall effect of 45mg minocycline and overall effect of 45 mg minocycline plus 15% azelaic acid in therapy of patients with acne rosacea.
Conditions Studied
Interventions
- DRUG Minocycline 45 MG
- DRUG Azelaic acid
Study Locations (1)
Kentucky
- Dermatology Specialists - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-09 |
| Phase | Phase 4 |
What the finished NCT05014906 record still lists
NCT05014906 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 240-participant average among 23 other Rosacea trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Rosacea appearing as the primary indexed condition, and to 2 interventions - of which Minocycline 45 MG is the first listed.
NCT05014906 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05014906 about?
NCT05014906 is a clinical study titled "Efficacy of Oral Minocycline (Solodyn) and Oral Minocycline (Solodyn) Plus Azelaic Acid (Finacea) for Acne Rosacea". Rosacea is one of the most commonly occurring dermatoses treated by dermatologist today. Rosacea is an inflammatory condition of the skin presenting as flushing and or blushing along with redness, swelling, telangiectasia, and acne lesions. Minocycline has shown beneficial in the treatment of inflam...
What is the current status of trial NCT05014906?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2010-05. Estimated completion is 2011-09.
What conditions does trial NCT05014906 study?
This clinical trial studies the following conditions: Rosacea.
What interventions are being tested in trial NCT05014906?
The interventions under investigation include: Minocycline 45 MG (DRUG), Azelaic acid (DRUG).
Who is sponsoring clinical trial NCT05014906?
This trial is sponsored by Dermatology Specialists Research, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05014906 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rosacea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05014906's enrollment target sits among peer trials
60 16th of 23 higher than 7 of 23 other Rosacea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rosacea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ORCA - Oracea® for Rosacea: A Community-based Assessment
COMPLETED · Phase 4
-
Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in Rosacea
RECRUITING · NA
-
Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea
RECRUITING · Phase 2
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
RECRUITING · NA
-
Analysis of the Microbiome in Rosacea
ACTIVE NOT RECRUITING · Early Phase 1
-
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia